Table 1 Blood chemistry values, BMD findings by DEXA, verterbral fractures, sarcopenia assessment
From: Bone damage after chemotherapy for lymphoma: a real-world experience
|  | N° (%) | Mean (SD) | |
|---|---|---|---|
Sex | Male | 19 (65.5) | Â |
Female | 10 (34.5) | ||
Age |  |  | 61.4 ± 16.7 |
BMI |  |  | 27.1 ± 4.3 |
Diagnosis | Hodgikin Lymphoma | 4 (13.8) | Â |
Non-Hodgikin Lymphoma | 25 (86.2) | ||
Histopathology (NHL) | DLBCL | 12 (48.0) | Â |
FL | 6 (24.0) | Â | |
MZL | 4 (16.0) | Â | |
CLL | 1 (4.0) | Â | |
MycosisFungoides | 1 (4.0) | Â | |
LGL leukemia | 1 (4.0) | Â | |
Comorbidities | ≥ 3 | 12 (41.4) |  |
1 or 2 | 10 (34.5) | ||
No | 7 (24.1) | ||
Chemotherapy | Yes | 29 (100.0) | Â |
No | 0 (0.0) | Â | |
Radiotherapy | Yes | 4 (13.8) | Â |
No | 25 (86.2) | Â | |
Corticosteroid Therapy | Yes | 17 (58.6) | Â |
No | 12 (41.4) | ||